김·장 법률사무소 지식재산권 그룹에서 분기별로 발행하는 영문 뉴스레터입니다.
기사 목록:
PATENT
- Korean District Court Recognizes Infringement of Pfizer's Patent for Prevenar 13® Based on Extraterritorial Activity
- KIPO Clarifies Written Description Requirements for Cosmetic Inventions
- Expedited Examination for Display Patent Applications Now Available
- Changes to Korea's Expedited Examination System and Patent Term Adjustment Practices in 2024
TRADEMARK, DESIGN & UNFAIR COMPETITION
- Supreme Court Issues Landmark Decision on the Criteria for Dilution Under the Trademark Act
- A Letter of Consent System Is Among the Notable Amendments to the Korean Trademark Act Coming Into Effect in 2024
- KIPO SJP's Investigative Authority to be Further Expanded
- New Applicant-Friendly Amendments to the Design Protection Act
- Expedited Examination of Korean Trademark Applications Has Become More Difficult Post-January 1, 2024
뉴스레터는 여기를 클릭하시거나 아래 파일을 다운로드 받으시면 열람하실 수 있습니다.
첨부파일 KIM & CHANG IP Newsletter_2023 Issue 4.pdf
관련 이슈
